Brown Advisory Inc Novartis Ag Transaction History

Brown Advisory Inc

  • $71.3 Billion
  • Q3 2025

A detailed history of Brown Advisory Inc transactions in Novartis Ag stock. As of the latest transaction made, Brown Advisory Inc holds 188,953 shares of NVS stock, worth $24.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
188,953
Previous 190,121 0.61%
Holding current value
$24.9 Million
Previous $23 Million 5.32%
% of portfolio
0.03%
Previous 0.03%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$113.5 - $129.73 $132,568 - $151,524
-1,168 Reduced 0.61%
188,953 $24.2 Million
Q2 2025

Aug 13, 2025
SELL
$101.96 - $121.01 $412,530 - $489,606
-4,046 Reduced 2.08%
190,121 $23 Million
Q1 2025

Apr 29, 2025
SELL
$97.14 - $115.57 $509,985 - $606,742
-5,250 Reduced 2.63%
194,167 $21.6 Million
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $323,341 - $391,498
-3,341 Reduced 1.65%
199,417 $19.4 Million
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $2.13 Million - $2.42 Million
-20,052 Reduced 9.0%
202,758 $23.3 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $982,260 - $1.14 Million
-10,611 Reduced 4.55%
222,810 $23.7 Million
Q1 2024

Apr 24, 2024
SELL
$95.27 - $108.47 $1.37 Million - $1.56 Million
-14,399 Reduced 5.81%
233,421 $22.6 Million
Q4 2023

Feb 08, 2024
SELL
$92.27 - $101.54 $3.64 Million - $4.01 Million
-39,471 Reduced 13.74%
247,820 $25 Million
Q3 2023

Oct 24, 2023
SELL
$94.73 - $105.13 $2.98 Million - $3.31 Million
-31,440 Reduced 9.86%
287,291 $29.3 Million
Q2 2023

Jul 31, 2023
SELL
$92.52 - $104.91 $2.16 Million - $2.45 Million
-23,368 Reduced 6.83%
318,731 $32.2 Million
Q1 2023

May 08, 2023
BUY
$80.03 - $92.81 $1.07 Million - $1.24 Million
13,381 Added 4.07%
342,099 $31.5 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $1.45 Million - $1.78 Million
-19,230 Reduced 5.53%
328,718 $29.8 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $299,260 - $349,999
-4,011 Reduced 1.14%
347,948 $26.4 Million
Q2 2022

Nov 14, 2022
BUY
$80.52 - $93.75 $596,009 - $693,937
7,402 Added 2.15%
351,959 $29.8 Million
Q2 2022

Sep 13, 2022
SELL
$80.52 - $93.75 $557,520 - $649,125
-6,924 Reduced 1.94%
349,127 $29.5 Million
Q2 2022

Aug 02, 2022
BUY
$80.52 - $93.75 $758,739 - $883,406
9,423 Added 2.72%
356,051 $30.3 Million
Q1 2022

Nov 14, 2022
SELL
$80.11 - $90.62 $366,102 - $414,133
-4,570 Reduced 1.31%
344,557 $30.2 Million
Q1 2022

Sep 13, 2022
SELL
$80.11 - $90.62 $192,103 - $217,306
-2,398 Reduced 0.69%
346,628 $30.4 Million
Q1 2022

May 09, 2022
BUY
$80.11 - $90.62 $958,676 - $1.08 Million
11,967 Added 3.55%
349,026 $30.6 Million
Q4 2021

Jan 27, 2022
SELL
$79.7 - $88.13 $1.23 Million - $1.36 Million
-15,395 Reduced 4.37%
337,059 $29.5 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $3.34 Million - $3.88 Million
40,781 Added 13.08%
352,454 $28.8 Million
Q2 2021

Jul 29, 2021
BUY
$85.24 - $94.15 $1.24 Million - $1.37 Million
14,520 Added 4.89%
311,673 $28.4 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $66,466 - $78,382
-796 Reduced 0.27%
297,153 $25.4 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $443,749 - $536,740
-5,684 Reduced 1.87%
297,949 $28.1 Million
Q3 2020

Nov 16, 2020
SELL
$82.14 - $91.0 $990,361 - $1.1 Million
-12,057 Reduced 3.82%
303,633 $26.4 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $7,445 - $8,381
-92 Reduced 0.03%
315,690 $27.6 Million
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $533,063 - $746,832
-7,543 Reduced 2.33%
315,782 $26 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $1.74 Million - $1.96 Million
-20,601 Reduced 5.99%
323,325 $30.6 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $165,776 - $182,675
-1,938 Reduced 0.56%
343,926 $29.9 Million
Q2 2019

Aug 12, 2019
SELL
$75.4 - $92.8 $446,066 - $549,004
-5,916 Reduced 1.68%
345,864 $31.6 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $277,478 - $317,376
-3,684 Reduced 1.04%
351,780 $33.8 Million
Q4 2018

Feb 13, 2019
BUY
$73.66 - $82.02 $451,830 - $503,110
6,134 Added 1.76%
355,464 $30.5 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $492,544 - $569,729
-7,358 Reduced 2.06%
349,330 $30.1 Million
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $1.05 Million - $1.18 Million
-16,118 Reduced 4.32%
356,688 $26.9 Million
Q1 2018

Jun 28, 2018
BUY
$70.39 - $84.15 $3.53 Million - $4.21 Million
50,089 Added 15.52%
372,806 $30.1 Million
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $3.13 Million - $3.75 Million
-44,535 Reduced 12.13%
322,717 $26.1 Million
Q4 2017

Feb 12, 2018
BUY
$72.33 - $77.64 $947,884 - $1.02 Million
13,105 Added 3.7%
367,252 $30.8 Million
Q3 2017

Nov 13, 2017
SELL
$74.14 - $77.27 $627,891 - $654,399
-8,469 Reduced 2.34%
354,147 $30.4 Million
Q2 2017

Aug 14, 2017
BUY
N/A
362,616
362,616 $30.3 Million

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email